SOBR Safe, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENT (Details Narrative)

SUBSEQUENT EVENT (Details Narrative) - USD ($)			1 Months Ended						12 Months Ended
SUBSEQUENT EVENT (Details Narrative) - USD ($)	Mar. 09, 2020	Jan. 03, 2020	Mar. 23, 2020	Jan. 16, 2020	Aug. 23, 2019	Apr. 30, 2018	Apr. 18, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Apr. 07, 2020	Apr. 06, 2020	Apr. 01, 2020	Mar. 21, 2020	Mar. 15, 2020	Mar. 02, 2020	Jan. 29, 2020	Jan. 22, 2020
Common stock, shares issued									214,626,540	109,409,930
Related Party [Member]
Debt conversion amount					$ 56,478			$ 8,204
Stock Options [Member]
Debt conversion amount						$ 4,500
Exercise Price Per Shares options exercised									$ 0.00	$ 0.01
Stock Options [Member] \| Maximum [Member]
Exercise Price Per Shares exercisable ending balance									0.00792	0.0045
Exercise price beginning balance									$ 0.25	$ 0.25
Subsequent Event [Member]
Amendment to Certificate of Incorporation, Dscription			To approve an amendment to the Companys Certificate of Incorporation to: (a) change the Company’s name to SOBR SAFE, Inc., (b) decrease the Companys authorized common stock from 800,000,000 shares, par value $0.00001 to 100,000,000 shares, par value $0.00001, and (c) effect a reverse stock split of the Companys outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders).
Subsequent Event [Member] \| Asset Purchase Agreement [Member]
Amendment to asset purchase agreement, dsecription	The parties further acknowledged that IDTEC, Gary Graham, First Capital Holdings, LLC and First Capital Ventures, LLC have voluntarily committed personnel and funds to the Company (Buyer) to assist with (i) ongoing operating expenses and pay for further engineering and development work on Buyer’s products and prototypes, (ii) protect, maintain and develop the Buyer’s products and intellectual property, (iii) hire, pay and retain the proposed management team, third party consultants and advisors for the Buyer following the consummation of the sale contemplated in the APA and, (iv) take such further actions as are necessary to more quickly expand the Buyer’s business subsequent to the sale of the purchased assets. The parties acknowledged that the amount voluntarily advanced by IDTEC is USD $1,416,076 as of February 20, 2020 (and will be a greater amount by the date the APA closes or is terminated). The parties agreed that that the $1,416,076 of funds were advanced voluntarily and are not the obligation of the Company and the Company has no obligation to repay these funds in the event the transaction contemplated by the APA does not close. In the event the transaction does close, then on the Closing Date, the Company shall issue promissory notes for the aggregate amounts incurred, paid or advanced.
Subsequent Event [Member] \| Asset Purchase Agreement One [Member]
Amendment to asset purchase agreement, dsecription	The parties further acknowledged that an affiliate of IDTEC purchased TransBiotec’s Series A-1 Convertible Preferred Stock in a separate transaction. TransBiotec previously agreed that it would, if requested in writing after the funding from the purchase of the TransBiotec Series A-1 Convertible Preferred Stock, pay up to USD $200,000 to IDTEC or its affiliates for the development of the SOBR device. In connection with the closing of the sale of the TransBiotec Series A-1 Convertible Preferred Stock, IDTEC requested, and TransBiotec paid in December 2019, a total of USD $141,000 to its affiliate for the development of the SOBR device.
Subsequent Event [Member] \| Common Stock Purchase Agreement [Member] \| Related Party [Member]
Common stock, shares issued											227,200	1,278,840	2,500,000			20,000	16,628,835
Common stock issued price per share											$ 0.0425	$ 0.10	$ 0.0175			$ 0.045	$ 0.0274608
Common stock issued to settle various promissory notes																	$ 456,641
Common stock issued to settle related party accounts payable											$ 9,656	$ 127,840	$ 43,753			$ 900
Subsequent Event [Member] \| Common Stock Purchase Agreement [Member] \| Non Related Party [Member]
Common stock, shares issued														19,500	325,000			238,143
Common stock issued price per share														$ 0.10	$ 0.10			$ 0.10
Common stock issued to settle accounts payable																		$ 23,814
Common stock issued to settle notes payable														$ 1,950	$ 32,500
Subsequent Event [Member] \| Common Stock Purchase Agreements [Member] \| Five Non-Affiliate Investors [Member]
Common stock, shares issued		4,605,847
Debt conversion amount		$ 460,585
Common stock issued price per share		$ 0.10
Subsequent Event [Member] \| Common Stock Purchase Agreements [Member] \| Two Non-Related Parties [Member]
Common stock, shares issued				1,274,636
Common stock issued price per share				$ 0.10
Common stock issued to settle accounts payable				$ 127,464
Subsequent Event [Member] \| Michael Lanphere [Member] \| Common Stock Purchase Agreement [Member]
Common stock, shares issued		2,102,854
Debt conversion amount		$ 210,285
Common stock issued price per share		$ 0.10
Subsequent Event [Member] \| Lanphere [Member] \| Common Stock Purchase Agreement [Member]
Common stock, shares issued		6,000,000
Debt conversion amount		$ 24,000
Common stock issued price per share		$ 0.004
Subsequent Event [Member] \| Lanphere One [Member] \| Common Stock Purchase Agreement [Member]
Common stock, shares issued		9,103,261
Debt conversion amount		$ 41,875
Common stock issued price per share		$ 0.0046
Subsequent Event [Member] \| Lanphere Two [Member] \| Common Stock Purchase Agreement [Member]
Common stock, shares issued				7,147,001
Debt conversion amount				$ 714,701
Common stock issued price per share				$ 0.10